Novel Method for Implantation of Balloon Expandable Transcatheter Aortic Valve Replacement to Reduce Pacemaker Rate—Line of Lucency Method

References

• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa1514616.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18):1696–1704. doi:10.1056/NEJMoa1202277.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa1103510.
   PubMed Web of Science ®Google Scholar
• Du F, Zhu Q, Jiang J, et al. Incidence and predictors of permanent pacemaker implantation in patients who underwent transcatheter aortic valve replacement: observation of a Chinese population. Cardiology. 2020;145(1):27–34. doi:10.1159/000502792.
   Web of Science ®Google Scholar
• Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129–140. doi:10.1016/j.jacc.2014.04.033.
   PubMed Web of Science ®Google Scholar
• Xi Z, Liu T, Liang J, Zhou YJ, Liu W. Impact of postprocedural permanent pacemaker implantation on clinical outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis. J Thorac Dis. 2019;11(12):5130–5139. doi:10.21037/jtd.2019.12.02.
   Web of Science ®Google Scholar
• Sathananthan J, Ding L, Yu M, et al. Implications of transcatheter heart valve selection on early and late pacemaker rate and on length of stay. Can J Cardiol. 2018;34(9):1165–1173. doi:10.1016/j.cjca.2018.06.012.
   Web of Science ®Google Scholar
• Gozdek M, Ratajczak J, Arndt A, et al. Transcatheter aortic valve replacement with Lotus and SAPIEN 3 prosthetic valves: a systematic review and meta-analysis. J Thorac Dis. 2020;12(3):893–906. doi:10.21037/jtd.2019.12.107.
   Web of Science ®Google Scholar
• Jatene T, Castro-Filho A, Meneguz-Moreno RA, et al. Prospective comparison between three TAVR devices: acurate neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2017;90(1):139–146. doi:10.1002/ccd.26837.
   Web of Science ®Google Scholar
• Ferreira ND, Caeiro D, Adao L, et al. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol. 2010;33(11):1364–1372. doi:10.1111/j.1540-8159.2010.02870.x.
   Web of Science ®Google Scholar
• van Gils L, Wohrle J, Hildick-Smith D, et al. Importance of contrast aortography with lotus transcatheter aortic valve replacement: a post hoc analysis from the RESPOND post-market study. JACC Cardiovasc Interv. 2018;11(2):119–128. doi:10.1016/j.jcin.2017.10.016.
   Web of Science ®Google Scholar
• Bhardwaj A, Ramanan T, Sawant AC, et al. Quality of life outcomes in transcatheter aortic valve replacement patients requiring pacemaker implantation. J Arrhythm. 2018;34(4):441–449. doi:10.1002/joa3.12065.
   PubMed Web of Science ®Google Scholar
• Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging. 2017;10(10Pt A):1139–1147. doi:10.1016/j.jcmg.2016.11.020.
   Google Scholar
• Piayda K, Hellhammer K, Veulemans V, et al. Navigating the “optimal implantation depth” with a self-expandable TAVR device in daily clinical practice. JACC Cardiovasc Interv. 2020;13(6):679–688. doi:10.1016/j.jcin.2019.07.048.
   Web of Science ®Google Scholar
• Krackhardt F, Kherad B, Krisper M, et al. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol. Cardiol J. 2017;24(3):250–258. doi:10.5603/CJ.a2017.0024.
   Web of Science ®Google Scholar
• Jilaihawi H, Zhao Z, Du R, et al. Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12(18):1796–1807. doi:10.1016/j.jcin.2019.05.056.
   PubMed Web of Science ®Google Scholar
• De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv. 2016;9(8):805–813. doi:10.1016/j.jcin.2015.12.023.
   PubMed Web of Science ®Google Scholar
• Murray MI, Geis N, Pleger ST, et al. First experience with the new generation Edwards SAPIEN 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol. 2015;28(1):109–116. doi:10.1111/joic.12182.
   Web of Science ®Google Scholar
• Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv. 2016;9(21):2200–2209. doi:10.1016/j.jcin.2016.08.034.
   PubMed Web of Science ®Google Scholar
• Tarantini G, Mojoli M, Purita P, et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention. 2015;11(3):343–350. doi:10.4244/EIJY14M11_06.
   Web of Science ®Google Scholar
• Koshy AN, Murphy A, Farouque O, Horrigan M, Yudi MB. Outcomes of transcatheter versus surgical aortic valve replacement in low-risk patients. Heart Lung Circ. 2020. doi:10.1016/j.hlc.2020.03.003.
   Web of Science ®Google Scholar
• Shivamurthy P, Vejpongsa P, Gurung S, et al. Validation of scoring system predicting permanent pacemaker implantation after transcatheter aortic valve replacement. Pacing Clin Electrophysiol. 2020;43(5):479–485. doi:10.1111/pace.13910.
   PubMed Web of Science ®Google Scholar
• Haunschild J, Misfeld M, Schroeter T, et al. Prevalence of permanent pacemaker implantation after conventional aortic valve replacement-a propensity-matched analysis in patients with a bicuspid or tricuspid aortic valve: a benchmark for transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2020;58(1):130–137. doi:10.1093/ejcts/ezaa053.
   PubMed Web of Science ®Google Scholar
• Ahmad M, Patel JN, Loc BL, et al. Permanent pacemaker implantation after transcatheter aortic valve replacement: a cost analysis. Cureus. 2019;11(6):e5005.
   Web of Science ®Google Scholar
• Chamandi C, Barbanti M, Munoz-Garcia A, et al. Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(3):301–310. doi:10.1016/j.jcin.2017.10.032.
   PubMed Web of Science ®Google Scholar
• Binder RK, Webb JG, Toggweiler S, et al. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv. 2013;6(5):462–468. doi:10.1016/j.jcin.2012.12.128.
   Web of Science ®Google Scholar
• Ramirez Del Val F, Hirji SA, Carreras ET, et al. Clinical significance of greater implantation height with SAPIEN 3 transcatheter heart valve. J Heart Valve Dis. 2018;27(1):9–16.
   Google Scholar
• Ahmad M, Patel JN, Kim M, et al. Larger valve size is associated with permanent pacemaker implantation in Edwards SAPIEN 3 transcatheter aortic valves. Cureus. 2019;11(4):e4370.
   Web of Science ®Google Scholar
• Biviano AB, Nazif T, Dizon J, et al. Atrial fibrillation is associated with increased pacemaker implantation rates in the placement of AoRTic transcatheter valve (PARTNER) trial. J Atr Fibrillation. 2017;10(1):1494. doi:10.4022/jafib.1494.
   Google Scholar
• Ahmad M, Patel JN, Loc BL, et al. Association between body mass index and permanent pacemaker implantation after transcatheter aortic valve replacement (TAVR) with Edwards SAPIEN 3 TAVR valves: a single-center experience. Cureus. 2019;11(7):e5142.
   Web of Science ®Google Scholar